News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McKenna Mark C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
4
| McKenna Mark C. (Director) has filed a Form 4 on Apogee Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $23.6, valued at
$1.2M
Granted 100,000 options to buy
@ $23.6, valued at
$2.4M
|
|
| 08/21/2023 |
3
| McKenna Mark C. (Director) has filed a Form 3 on Apogee Therapeutics, Inc. |
| 06/16/2023 |
4
| McKenna Mark C. (Chairman, President and CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 178,098 shares
@ $0
Disposed/sold 161,105 options to buy
@ $2.9, valued at
$467.2k
Disposed/sold 132,741 options to buy
@ $1.7, valued at
$225.7k
Disposed/sold 20,000 options to buy
@ $3.1, valued at
$62k
Disposed/sold 481,725 options to buy
@ $3.7, valued at
$1.8M
Disposed/sold 566,307 options to buy
@ $6.7, valued at
$3.8M
Disposed/sold 290,000 options to buy
@ $36.32, valued at
$10.5M
Disposed/sold 246,639 options to buy
@ $29.56, valued at
$7.3M
Disposed/sold 128,930 options to buy
@ $110.2, valued at
$14.2M
|
|
| 06/02/2023 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Exercised 122,528 options to buy
@ $2.9, valued at
$355.3k
Exercised 3 options to buy
@ $1.7, valued at
$5.1 |
|
| 03/17/2023 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Sold 25,000 shares
@ $116.14, valued at
$2.9M
Exercised 25,000 options to buy
@ $2.9, valued at
$72.5k
|
|
| 03/03/2023 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Sold 700 shares
@ $125.26, valued at
$87.7k
Sold 10,620 shares
@ $125.13, valued at
$1.3M
Exercised 700 options to buy
@ $3.7, valued at
$2.6k
Exercised 10,620 options to buy
@ $3.7, valued at
$39.3k
|
|
| 01/19/2023 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Sold 25,000 shares
@ $118.99, valued at
$3M
Exercised 25,000 options to buy
@ $2.9, valued at
$72.5k
|
|
| 12/13/2022 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 37,113 shares
@ $0
Granted 128,930 options to buy
@ $110.2, valued at
$14.2M
|
|
| 05/20/2022 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 246,639 options to buy
@ $29.56, valued at
$7.3M
|
|
| 12/03/2021 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Exercised 15,400 options to buy
@ $2.9, valued at
$44.7k
|
|
| 11/16/2021 |
4
| McKenna Mark C. (Chairman, President & CEO) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 290,000 options to buy
@ $36.32, valued at
$10.5M
|
|
| 03/11/2021 |
3
| McKenna Mark C. (President and CEO) has filed a Form 3 on Prometheus Biosciences, Inc. |
| 08/21/2019 |
4
| McKenna Mark C. (President, Salix) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Sold 10,773 shares
@ $21.8343, valued at
$235.2k
|
|
| 06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2019 |
4
| McKenna Mark C. (President, Salix) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Paid exercise price by delivering 746 shares
@ $23.51, valued at
$17.5k
|
|
| 03/12/2019 |
4
| McKenna Mark C. (President, Salix) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Paid exercise price by delivering 974 shares
@ $23.56, valued at
$22.9k
|
|
| 03/01/2019 |
4
| McKenna Mark C. (President, Salix) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Granted 15,221 shares
@ $0
Granted 44,290 options to buy
@ $23.16, valued at
$1M
|
|
| 01/10/2019 |
4
| McKenna Mark C. (President, Salix) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Paid exercise price by delivering 1,190 shares
@ $21.25, valued at
$25.3k
|
|
| 08/10/2018 |
3
| McKenna Mark C. (President, Salix) has filed a Form 3 on Bausch Health Companies Inc. |
|
|